PROTAC-induced proteolytic targeting
- PMID: 22350917
- PMCID: PMC3852687
- DOI: 10.1007/978-1-61779-474-2_44
PROTAC-induced proteolytic targeting
Abstract
Small-molecule modulators of protein activity are increasingly being utilized as tools to examine the functional roles of proteins. Operating at the post-translational level, these molecules provide enhanced temporal and spatial control and mitigate the potential for compensatory responses in comparison with classical genetic approaches. Proteolysis targeting chimeric molecules, or PROTACs, are small molecules that inhibit the function of their target proteins by targeting them for degradation by the ubiquitin proteasome system. This chapter summarizes strategies for PROTAC preparation and characterization.
Figures


Similar articles
-
PROTAC-DB 2.0: an updated database of PROTACs.Nucleic Acids Res. 2023 Jan 6;51(D1):D1367-D1372. doi: 10.1093/nar/gkac946. Nucleic Acids Res. 2023. PMID: 36300631 Free PMC article.
-
Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.Mol Cells. 2018 Nov 30;41(11):933-942. doi: 10.14348/molcells.2018.0372. Epub 2018 Nov 7. Mol Cells. 2018. PMID: 30486612 Free PMC article. Review.
-
Cellular parameters shaping pathways of targeted protein degradation.Commun Biol. 2025 May 2;8(1):691. doi: 10.1038/s42003-025-08104-w. Commun Biol. 2025. PMID: 40316744 Free PMC article. Review.
-
Recent Advances in PROTACs for Drug Targeted Protein Research.Int J Mol Sci. 2022 Sep 7;23(18):10328. doi: 10.3390/ijms231810328. Int J Mol Sci. 2022. PMID: 36142231 Free PMC article. Review.
-
Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool.Commun Biol. 2021 May 28;4(1):640. doi: 10.1038/s42003-021-02158-2. Commun Biol. 2021. PMID: 34050235 Free PMC article.
Cited by
-
Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells.Neoplasia. 2019 Nov;21(11):1110-1120. doi: 10.1016/j.neo.2019.10.003. Epub 2019 Nov 14. Neoplasia. 2019. PMID: 31734632 Free PMC article.
-
BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells.Cell Death Dis. 2020 Oct 22;11(10):900. doi: 10.1038/s41419-020-03117-1. Cell Death Dis. 2020. PMID: 33093476 Free PMC article.
-
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases.Front Immunol. 2016 Mar 31;7:123. doi: 10.3389/fimmu.2016.00123. eCollection 2016. Front Immunol. 2016. PMID: 27065076 Free PMC article. Review.
-
TrypPROTACs Unlocking New Therapeutic Strategies for Chagas Disease.Pharmaceuticals (Basel). 2025 Jun 19;18(6):919. doi: 10.3390/ph18060919. Pharmaceuticals (Basel). 2025. PMID: 40573314 Free PMC article. Review.
-
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs.RSC Adv. 2020 Dec 24;11(2):612-636. doi: 10.1039/d0ra07971e. eCollection 2020 Dec 24. RSC Adv. 2020. PMID: 35746919 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources